Covalent Surface Modification of Fe3O4 Magnetic Nanoparticles with Alkoxy Silanes and Amino Acids

Covalent Surface Modification of Fe3O4 Magnetic Nanoparticles with Alkoxy Silanes and Amino Acids

Mendeleev Communications Mendeleev Commun., 2013, 23, 14–16 Covalent surface modification of Fe3O4 magnetic nanoparticles with alkoxy silanes and ami...

1MB Sizes 0 Downloads 101 Views

Mendeleev Communications Mendeleev Commun., 2013, 23, 14–16

Covalent surface modification of Fe3O4 magnetic nanoparticles with alkoxy silanes and amino acids Alexander M. Demin,* Victor P. Krasnov and Valery N. Charushin I. Ya. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, 620990 Ekaterinburg, Russian Federation. Fax: +7 343 369 3058; e-mail: [email protected] DOI: 10.1016/j.mencom.2013.01.004

(3-Aminopropyl)silane-modified magnetic nanoparticles containing e-aminocaproic acid and l-lysine frag­ments with free functional groups were obtained by the surface modification of Fe3O4 with alkoxysilane derivatives.



Fe3O4 nanoparticles (20–40 nm) were obtained by gas condensation at the Institute of Metal Physics, Ural Branch of the Russian Academy of Sciences. ‡ After pre-activation (treatment of the original MNPs with 0.05 n NaOH) alkoxysilane reagent 1 (2, 3 or 4) was added to a suspension of MNPs, and the reaction mixture was stirred for 16–20 h. § The IR spectra were recorded using a Nicolet 6700 FT-IR spectrometer (Thermo Electron Corporation). Elemental analysis was carried out on a Perkin Elmer PE 2400 (series II CHNS-O EA 1108) instrument. © 2013 Mendeleev Communications. All rights reserved.

Fe3O4

RO RO Si OR 1–4

OH

0.05 N NaOH

Fe3O4

OH

1, 5 R = Me, R1 = NH2 2, 5 R = Et, R1 = NH2

O Fe3O4

O

R1

Si

O

R1

EtOH

OH

3, 6 R = Et, R1 = O 4, 7 R = Me, R1 = SH

5–7

O

Scheme  1  Functionalization of the MNP surface with alkoxysilanes 1–4.

1010

3

1188

1

543

1072 988

5

1202

808 768

1188

2

1026

1074

816 777 756

1190

7

547

4

1237 1174

Transmittance (arbitrary units)

543

1104

6

1500

1000 n/cm–1

550

1074

803 785

752

1188

New materials based on g-Fe2O3 and Fe3O4 magnetic nano­ particles (MNPs) with ferromagnetic properties are of interest for targeted drug delivery, magnetic resonance imaging, hyper­ thermic treatment of tumors and other medical applications.1,2 The successful implementation of MNPs is associated with the chemical modifications of their surface by coating nanoparticles with functionalized polymers and biopolymers.3,4 An efficient approach is the covalent linkage of organic molecules to MNPs using alkoxysilane reagents.5–11 Organic molecules can be attached to MNPs via interaction with the surface alkoxysilane functional groups or by using bifunctional linkers, such as e-aminocaproic acid (e-ACA)12 or l-lysine.13 The aim of this study was to develop new methods for modi­ fication of Fe3O4 MNPs (20–40 nm)† with silane derivatives, such as (3-aminopropyl)trimethoxysilane (APTMS) (1), (3-amino­ propyl)triethoxysilane (APTES) (2), (3-glycidyloxypropyl)tri­ ethoxysilane (GPTES) (3), and (3-mercaptopropyl)trimethoxy­ silane (MPTMS) (4), followed by the modification of the surface layer with e-ACA or l-lysine as linkers. The surface properties of MNPs obtained by chemical methods from aqueous solutions and those obtained by gas condensation are strongly different. The MNPs obtained from solutions have a hydrophilic surface, which makes it possible to functionalize them with alkoxysilane derivatives. In the latter case, MNPs have a hydrophobic surface, which complicates the surface modification using standard tech­ niques. First, we studied the effects of solvents and the ratio of reactants on the degree of silanization with compounds 1–4 (Scheme 1).‡ The immobilization of propylsilanes 1–4 on the MNP surface was confirmed by IR spectroscopy (Figure 1) and elemental analysis.§ Anhydrous and 95 % aqueous ethanol, benzene containing 1% water, benzene dried over Na and water were used as solvents in the condensation reaction. The best results were obtained using 95% ethanol. An amount of alkoxysilane needed to achieve the maximum degree of MNP modification was 2.5–3.0 mmol of APTMS or APTES per gram of MNPs, while in case of GPTES and MPTMS these values were 1.0–1.5 mmol. These ratios were found as a result of the condensation of MNPs suspensions in

500

Figure  1  FT-IR spectra of (1) the original MNPs, (2) APTMS 1, (3) APSmodified MNPs 5, (4) GPTES 3, (5) GPS-modified MNPs 6, (6) MPTMS 4, and (7) MPS-modified MNPs 7. ¶

Morphological studies of particles were performed using a Philips CM30 transmission electron microscope (TEM). †† The mass fraction of silicon was determined on an iCAP6300 Duo optical emission spectrometer with inductively coupled plasma (ICP-OES) (Thermo Scientific).

–  14  –

Mendeleev Commun., 2013, 23, 14–16 O

1

MeCN

But

O

O R=

H N R1

1641

6 7 8

O

O

1687

12, 18: =H 13, 19: R1 = NH

ethanol (95%) with 0.25, 0.50, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0 and 10 mmol of alkoxysilane per gram of MNPs. According to the TEM data¶ obtained for APS- (5) and (3-gly­ cidyloxypropyl)silane-modified (GPS-modified) (6) MNPs, no difference in the morphology of the original and modified nano­ particles was observed. As for (3-mercaptopropyl)silane-modi­fied (MPS-modified) MNPs (7), a substantial thickening of the surface layer was observed due to a profound tendency of mercapto groups towards oxidation into disulfides and also because of a plausible S–Fe bond formation in some cases. Quantitative estima­ tion of the degree of immobilization of silane derivatives on the MNPs surface was carried out by ICP-OES†† and elemental analysis. The degree of immobilization of APS in cases of APTMS and APTES was 0.7–1.0 mmol g–1. Modified Fe3O4 nanocom­ posites 6 and 7 contained 0.3 and 2.1 mmol g–1 of the silane fragments attached to MNPs, respectively. The presence of amino groups in the structure of APS-modi­fied MNPs allows one to further modify them with amino acids and peptides bearing free carboxylic groups. We carried out the coupling reaction of the APS-modified MNPs with N-protected derivatives of e-ACA (8, 10, 12) and l-lysine (9, 11, 13) (Scheme 2). Three

Si

O

N H

O

Si

O

1250

543

1032

500

Figure  2  FT-IR spectra of (1) APS-modified MNPs 5, (2) MNPs 18 immobilized with N-Fmoc-e-ACA, (3) MNPs 19 immobilized with di-Fmocl-lysine, (4) MNPs 14 immobilized with N-Boc-e-ACA, (5) MNPs 15 immobilized with di-Boc-l-lysine, (6) MNPs 16 immobilized with N-TFAe-ACA, (7) MNPs 17 immobilized with di-TFA-l-lysine, and (8) di-Fmocl-lysine 13 (for example).

types of N-protecting groups were chosen: tert-butyloxycarbonyl (Boc), which can be removed under acidic conditions, trifluoro­ acetyl (TFA) removable under alkaline conditions, and fluorenyl­ methyloxycarbonyl (Fmoc), which can be removed in the presence of organic bases. Since a similar reaction with 1-ethyl-3-(3-di­ methylaminopropyl)carbodiimide (EDC) as a coupling agent proceeds smoothly in acetonitrile solution,14 we used the same reaction conditions (Scheme 2). The FT-IR spectra of the reaction products exhibit absorption bands that are characteristic of the starting materials; however, these bands are shifted (Figure 2), thus indicating that the covalent binding of amino acids to amino groups on the modified MNPs takes place. The amounts of the immobilized amino acid derivatives were calculated by the carbon mass fraction found from the elemental analysis data for the amino acid-modified MNPs. The best results were obtained using di-Fmocl-lysine 19 (to 0.14 mmol g–1), Boc- 14 and Fmoc-e-ACA 18 (0.15 mmol g–1 in both cases). Another task of this work was to prepare MNPs 20 and 21 modified with e-ACA and l-lysine with free amino groups

TFA

R

N H

0.005 or 0.015 N NaOH 4

NHTFA

R

16, 17

acetone (or H2O)

O

O O

NHBoc

O

O

Fe3O4

4

14, 15

O Fe3O4

1000 n/cm–1

O

O O

1251

1500

O

Scheme  2  Coupling of N-protected derivatives of e-ACA and l-lysine to APS-modified MNPs.

Fe3O4

1528 1449

O

R1

539

O

CF3

632

10, 16: =H 11, 17 R1 = HN

1263

O

1728

8, 14 =H 9, 15: R1 = HN

5

587

O

R1

4

1010

R1

R1

CF3

980

O

H N

1367

R=

1532 1447

R1

O But

1530

O

1695

H N

R=

3

1691

O

14–19

2 R

1702 1645

O

N H

1625 1548

Si

1621 1539

O

1119

O

O Fe3O4

1009

5

633 588

O

ROH (8–13), EDC

NH2

Si

1017

O

Transmittance (arbitrary units)

Fe3O4

piperidine

Si

N H 18, 19

4

R

NHFmoc

DMF (or EtOH)

O

O Fe3O4

O O

Si

N H 20, 21

14, 16, 18, 20 15 17 19 21

4

R

NH2

R=H R = NHBoc R = NHTFA R = NHFmoc R = NH2

Scheme  3  Removal of N-protecting groups from e-ACA and l-lysine derivatives immobilized on the APS-modified MNPs.

–  15  –

Mendeleev Commun., 2013, 23, 14–16

and an opportunity for further functionalization of the surface of APS-modified MNPs with N-protected derivatives of e-ACA and l-lysine was shown. The best results were obtained using di-Fmoc-l-lysine, Boc- and Fmoc-e-ACA. Appropriate condi­ tions for the removal of protecting groups and the prepara­tion of MNPs containing amino acid fragments with free func­tional groups were found. Both qualitative and quantitative evaluation procedures for the immobilization of propylsilane and amino acid derivatives on the MNPs have been advanced using IR spectro­ scopy, elemental analysis data and ICP-OES.

1009

1

1107

We are grateful to Dr. M. A. Uimin and Professor A. E. Yermakov (Institute of Metal Physics, Ural Branch of the Russian Academy of Sciences) for the pre­para­tion of Fe3O4 MNPs and to Dr. N. N. Shchegoleva for the morphological studies of nanocomposites. This work was sup­ported by the Ural Branch of the Russian Academy of Sciences (project nos. 12-P-234-2003 and 12-P-31030), the Ministry of Industry and Science of Sverdlovsk Region and the Russian Foundation for Basic Research (project no. 10-0396003-r_ural_a) and the State Programme for the Support of Leading Scientific Schools (grant no. NSh 5505.2012.3).

630 591

1101 1059 1206

619 571

1642 1565

1013

4

634 585

543

1022

1525

1690 1654

3

1713 1648 1609 1528 1448

Transmittance (arbitrary units)

2

1500

1000 n/cm–1

500

Figure  3  FT-IR spectra of (1) the APS-modified MNPs 5, (2) MNPs 19 immobilized with di-Fmoc-l-lysine, (3) MNPs 15 immobilized with di-Bocl-lysine, and (4) MNPs 21 immobilized with l-lysine.

(Scheme 3). The nanocomposites are stable under acidic condi­ tions in concentrated trifluoroacetic acid. The treatment of a suspension of MNPs 14 and 15 with concentrated trifluoroacetic acid for 30 min resulted in the complete removal of the Boc protecting group, thus giving compounds 20 and 21. The removal of Fmoc groups from the amino acid fragments of MNPs 18 and 19 was carried out by reacting with piperidine in ethanol for 24–30 h. We failed to obtain MNPs 20 and 21 on the treatment of MNPs 16 and 17 with a 1.2 molar excess of NaOH (relative to the corresponding amino acid). The alkaline conditions lead to a significant degradation of nanocomposites. It did occur simul­ taneously with the removal of TFA protection and was accom­ panied by a marked cleavage of amino acid derivatives from the MNPs surface due to the breakage of the Si–O–Fe bond. The degree of removal of protecting groups was estimated by FT-IR spectroscopy (Figure 3). In order to evaluate quantitatively the immobilized amino acids, we subtracted the carbon mass fraction of the starting APS-modified MNPs from the carbon mass fraction found from the elemental analysis data for the amino acid-modified MNPs. Based on the obtained carbon mass fraction, we calculated the amount of immobilized amino acid. The removal of Fmoc groups from the l-lysine fragment resulted in the MNPs containing up to 0.10 mmol of amino acid fragments per gram of nanoparticles. After the removal of Boc and Fmoc protections from e-ACA, we obtained MNPs containing up to 0.14 mmol g–1. In conclusion, note that the chemical modification of Fe3O4 MNPs via covalent bond formation with trialkoxysilane deriva­ tives (APTMS, APTES, GPTES and MPTMS) was performed,

Online Supplementary Materials Supplementary data associated with this article can be found in the online version at doi:10.1016/j.mencom.2013.01.004. References   1 Theranostic Nanomedicine Special issue, Acc. Chem. Res., 2011, 44, 841.   2 C. Sanchez, P. Belleville, M. Popall and L. Nicole, Chem. Soc. Rev., 2011, 40, 696.   3 J. K. Oh and J. M. Park, Prog. Polym. Sci., 2011, 36, 168.   4 O. Veiseh, J.W. Gunn and M. Zhang, Adv. Drug Delivery Rev., 2010, 62, 284.   5 R. A. Bini, R. F. C. Marques, F. J. Santos, J. A. Chaker and M. Jafelicci, Jr., J. Magn. Magn. Mater., 2012, 324, 534.   6 F. Galeotti, F. Bertini, G. Scavia and A. Bolognesi, J. Colloid Interface Sci., 2011, 360, 540.   7 N. Frickel, R. Messing, T. Gelbrich and A. M. Schmidt, Langmuir, 2010, 26, 2839.   8 C. Zhang, B. Wangler, B. Morgenstern, H. Zentgraf, M. Eisenhut, H. Unte­necker, R. Kruger, R. Huss, C. Seliger, W. Semmler and F. Kiessling, Langmuir, 2007, 23, 1427.   9 N. R. Jana, C. Earhart and J. Y. Ying, Chem. Mater., 2007, 19, 5074. 10 A. Campo, T. Sen, J. Lellouche and I. J. Bruce, J. Magn. Magn. Mater., 2005, 293, 33. 11 I. J. Bruce and T. Sen, Langmuir, 2005, 21, 7029. 12 B. Srinivasan and X. Huang, Chirality, 2008, 20, 265. 13 C.-H. Liu, W.-C. Wu, H.-Y. Lai and H.-Y. Hou, J. Biosci. Bioeng., 2011, 112, 219. 14 A. M. Demin, M. A. Uimin, N. N. Shchegoleva, A. E. Yermakov and V. P. Krasnov, Rossiiskie Nanotekhnologii, 2012, 7, 66 (Nanotechnologies in Russia, 2012, 7, 132).

Received: 19th September 2012; Com. 12/3981

–  16  –